WilBio-Europe Antibodies & Recombinant Proteins
Title | WilBio-Europe Antibodies & Recombinant Proteins PDF eBook |
Author | |
Publisher | |
Pages | |
Release | 2005 |
Genre | |
ISBN |
Modern Biopharmaceuticals
Title | Modern Biopharmaceuticals PDF eBook |
Author | Jörg Knäblein |
Publisher | John Wiley & Sons |
Pages | 724 |
Release | 2013-05-07 |
Genre | Science |
ISBN | 3527669434 |
This collection of high-profile contributions provides a unique insight into the development of novel, successful biopharmaceuticals. Outstanding authors, including Nobel laureate Robert Huber as well as prominent company researchers and CEOs, present valuable insider knowledge, limiting their scope to those procedures and developments with proven potential for the biotechnology industry. They cover all relevant aspects, from the establishment of biotechnology parks, the development of successful compounds and the implementation of efficient manufacturing processes, right up to the establishment of advanced delivery routes.
Process Scale Purification of Antibodies
Title | Process Scale Purification of Antibodies PDF eBook |
Author | Uwe Gottschalk |
Publisher | John Wiley & Sons |
Pages | 849 |
Release | 2017-03-07 |
Genre | Medical |
ISBN | 1119126932 |
Promoting a continued and much-needed renaissance in biopharmaceutical manufacturing, this book covers the different strategies and assembles top-tier technology experts to address the challenges of antibody purification. • Updates existing topics and adds new ones that include purification of antibodies produced in novel production systems, novel separation technologies, novel antibody formats and alternative scaffolds, and strategies for ton-scale manufacturing • Presents new and updated discussions of different purification technologies, focusing on how they can address the capacity crunch in antibody purification • Emphasizes antibodies and innovative chromatography methods for processing
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Title | The Challenge of CMC Regulatory Compliance for Biopharmaceuticals PDF eBook |
Author | John Geigert |
Publisher | Springer |
Pages | 426 |
Release | 2019-05-08 |
Genre | Medical |
ISBN | 3030137546 |
Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the innovators and biosimilars); but now, an increasing awareness of the importance of gene therapy and genetically engineered cellular medicinal products. These biopharmaceuticals are being developed by many companies whose Chemistry, Manufacturing & Control (CMC) teams have varying degrees of familiarity or experience with the CMC strategy and regulatory compliance requirements for these challenging products. Companies clearly plan out the strategy for their clinical study plans, but frequently, the development of a strategy for CMC is an afterthought. Coupled with the complexity of the biopharmaceutical manufacturing processes and products, and this can be a recipe for disaster. The third edition of this book provides insights and practical guidance for the CMC teams to develop an acceptable cost-effective, risk-based CMC regulatory compliance strategy for all biopharmaceuticals (recombinant proteins, monoclonal antibodies, genetically engineered viruses and genetically engineered human cells) from early clinical stage development through market approval. The third edition of this book provides added coverage for the biosimilars, antibody drug conjugates (ADCs), bispecific antibodies, genetically engineered viruses, and genetically engineered cells. This third edition of the book also addresses the heightened pressure on CMC regulatory compliance timelines due to the introduction of expedited clinical pathways moving the clinical development closer to a seamless phase process (e.g., FDA Breakthrough Therapy designation, CBER Regenerative Medicine Advanced Therapy (RMAT) designation, EMA Priority Medicines (PRIME) designation). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals is essential, practical information for all pharmaceutical development scientists, Manufacturing and Quality Unit staff, Regulatory Affairs personnel, and senior management involved in the manufacture of biopharmaceuticals.
Viral Vectors for Gene Therapy
Title | Viral Vectors for Gene Therapy PDF eBook |
Author | Otto-Wilhelm Merten |
Publisher | Humana |
Pages | 0 |
Release | 2011-05-19 |
Genre | Medical |
ISBN | 9781617790942 |
The huge potential for gene therapy to cure a wide range of diseases has led to high expectations and a great increase in research efforts in this area, particularly in the study of delivery via viral vectors, widely considered to be more efficient than DNA transfection. In Viral Vectors for Gene Therapy: Methods and Protocols, experts in the field present a collection of their knowledge and experience featuring methodologies that involve virus production, transferring protocols, and evaluating the efficacy of gene products. While thoroughly covering the most popular viral vector systems of adenovirus, retrovirus, and adeno-associated virus, this detailed volume also explores less common viral vector systems such as baculovirus, herpes virus, and measles virus, the growing interest in which is creating a considerable demand for large scale manufacturing and purification procedures. Written in the highly successful Methods in Molecular BiologyTM series format, many chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and vital tips on troubleshooting and avoiding known pitfalls. Comprehensive and practical, Viral Vectors for Gene Therapy: Methods and Protocols provides basic principles accessible to scientists from a wide variety of backgrounds for the development of gene therapy viral products that are safe and effective.
Pharmaceutical Biotechnology
Title | Pharmaceutical Biotechnology PDF eBook |
Author | Daan J. A. Crommelin |
Publisher | CRC Press |
Pages | 456 |
Release | 2002-11-14 |
Genre | Medical |
ISBN | 9780415285018 |
The field of pharmaceutical biotechnology is evolving rapidly. A whole new arsenal of protein pharmaceuticals is being produced by recombinant techniques for cancer, viral infections, cardiovascular and hereditary disorders, and other diseases. In addition, scientists are confronted with new technologies such as polymerase chain reactions, combinatorial chemistry and gene therapy. This introductory textbook provides extensive coverage of both the basic science and the applications of biotechnology-produced pharmaceuticals, with special emphasis on their clinical use. Pharmaceutical Biotechnology serves as a complete one-stop source for undergraduate pharmacists, and it is valuable for researchers and professionals in the pharmaceutical industry as well.
International Complete Collection of R&D Information about Traditional Chinese Materia Medica and Biotechnology Enterprises
Title | International Complete Collection of R&D Information about Traditional Chinese Materia Medica and Biotechnology Enterprises PDF eBook |
Author | Zhengsong Zhan |
Publisher | World Scientific |
Pages | 1006 |
Release | 2010-04-01 |
Genre | Medical |
ISBN | 9814291560 |
The International Complete Collection of R&D Information about Traditional Chinese Materia Medica (TCMM) and Biotechnology (BT) Enterprises is designed as an informative medicinal reference directory listing of up-to-date R&D information about TCMM, medical biotechnology, and related medical equipment companies. The focus of this valuable and practical directory is on providing a comprehensive coverage of the most recent developments in scientific research, patents and major products of about 3,000 companies from 50 countries covering the five continents: Asia, Europe, America, Africa and the Oceania. The resource material and information are relevant and compulsory to practitioners and professionals in the fields of TCMM, medical biotechnology, biochemical industry and related medical instrumentation/equipment, as well as to organizational departments of the medicinal information management, intelligence, logistics and trade. The directory also opens up and serves as an important window through which biotech professionals master product information of their counterparts across the world. The directory will benefit professionals of medical heath, TCMM, biotechnology and related fields, as well as academics and students, executives of research, information media staffs and translators.